Skip to main content
The NCI Community Hub will be retiring in May 2024. For more information please visit the NCIHub Retirement Page:https://ncihub.cancer.gov/groups/ncihubshutdown/overview
close

Vanderbilt PC9 cell line exposed to varying concentrations of erlotinib

By Vito Quaranta1, Shawn Garbett1, Jonathan Bistline2

1. Vanderbilt University Medical Center 2. Broad Institute

Download (TXT)

Additional materials available (25)

Licensed according to this deed.

Category

Downloads

Published on

Abstract

Histone H2B labeled PC9 NSCLC cell line exposed to varying concentrations of erlotinib.  There are twenty-five (25) files in this study:

1-24. Cell Motility Movies (*.mov)

25. Sample Annotation (2011-06-13_PC9_erlot_plate_map.txt)

These datasets have been exported from the Broad Institute's ICBP Data & Analysis Portal.

Cite this work

Researchers should cite this work as follows:

  • Vito Quaranta; Shawn Garbett; Jonathan Bistline (2014), "Vanderbilt PC9 cell line exposed to varying concentrations of erlotinib," https://ncihub.cancer.gov/resources/672.

    BibTex | EndNote

Tags

  1. cell motility
  2. ICBP